Hanibal Bohnenberger

Robert Koch Str. 40
Goettingen, NI 37075, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 104 publications

Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variability.

Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variability.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 05, 2026

Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort.

Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: November 13, 2025

Spatially-resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma.

Spatially-resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma.

Journal: Molecular cancer

Published: November 10, 2025

Targeting histone deacetylation, cell cycle regulators and heat shock proteins as novel therapeutic strategies for penile cancers.

Targeting histone deacetylation, cell cycle regulators and heat shock proteins as novel therapeutic strategies for penile cancers.

Journal: NPJ precision oncology

Published: August 07, 2025

DLL3 Expression in Neuroendocrine Carcinomas and Neuroendocrine Tumours: Insights From a Multicentric Cohort of 1294 Pulmonary and Extrapulmonary Neuroendocrine Neoplasms.

DLL3 Expression in Neuroendocrine Carcinomas and Neuroendocrine Tumours: Insights From a Multicentric Cohort of 1294 Pulmonary and Extrapulmonary Neuroendocrine Neoplasms.

Journal: Endocrine pathology

Published: March 16, 2025

Current practice of pathologic response assessment following chemoimmunotherapy for non-small cell lung cancer (NSCLC) in Germany: first real-world data from the multicentre Re-GraDE study.

Current practice of pathologic response assessment following chemoimmunotherapy for non-small cell lung cancer (NSCLC) in Germany: first real-world data from the multicentre Re-GraDE study.

Journal: Histopathology

Published: February 18, 2025

Increased expression of FBW7 may improve the prognosis of lung adenocarcinoma after pemetrexed chemotherapy by transforming the epithelial-to-mesenchymal process.

Increased expression of FBW7 may improve the prognosis of lung adenocarcinoma after pemetrexed chemotherapy by transforming the epithelial-to-mesenchymal process.

Journal: Journal of thoracic disease

Published: January 19, 2025

Proteasome inhibition as a potential therapeutic target in thymic cancer.

Proteasome inhibition as a potential therapeutic target in thymic cancer.

Journal: Cell death & disease

Published: January 08, 2025

New methods at the transition from research to routine diagnostics

New methods at the transition from research to routine diagnostics

Journal: Pathologie (Heidelberg, Germany)

Published: December 23, 2024

Expression and prongostic impact of galectin-7 in human lung cancer.

Expression and prongostic impact of galectin-7 in human lung cancer.

Journal: Medicine

Published: October 28, 2024

MTHFD2 marks pemetrexed resistance in pulmonary adenocarcinoma with EGFR wild type.

MTHFD2 marks pemetrexed resistance in pulmonary adenocarcinoma with EGFR wild type.

Journal: Discover oncology

Published: October 12, 2024

Effects of chemoradiotherapy on surface PD-L1 expression in esophageal cancer and its implications for immunotherapy.

Effects of chemoradiotherapy on surface PD-L1 expression in esophageal cancer and its implications for immunotherapy.

Journal: Frontiers in immunology

Published: October 10, 2024

Showing 1-12 of 104

Last Updated: 09/26/2026